PD-1 and LAG-3 Double-Positive T Cells Predict Better Gastric Cancer Survival
A multicohort study finds that gastric tumors rich in PD-1 and LAG-3 double-positive CD8 T cells—an activated, pre-exhausted population—are linked ...
A multicohort study finds that gastric tumors rich in PD-1 and LAG-3 double-positive CD8 T cells—an activated, pre-exhausted population—are linked ...
Scientists have transformed a sugar molecule produced by gut bacteria into a self-assembling nanovaccine that dramatically boosts antitumor immunity and ...
New research shows that combining sunitinib with 177Lu-DOTATATE radiotherapy triggers immunogenic cell death in pancreatic neuroendocrine tumors, recruiting antitumor T ...
A retrospective study of 195 colorectal cancer patients found that removing twenty or more tumor-draining lymph nodes after neoadjuvant immunotherapy ...
A new review shows that physical exercise can remodel the tumor microenvironment to convert immunologically cold tumors into treatment-responsive ones ...
Researchers have identified ANKRD11 as a chromatin regulator whose loss reprograms CD8+ T cells to fight chronic hepatitis B and ...
Adelaide University researchers have developed mRNA lipid nanoparticles that reprogram immunosuppressive tumour-associated macrophages to recruit cancer-fighting T cells, showing reduced ...
Recent groundbreaking research published in the prestigious journal Cell reveals a fascinating and previously uncharted feature on the surface of ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine